Journal article icon

Journal article : Review

Prevalence of antidepressant prescriptions for community-dwelling adults diagnosed with depressive disorder in the UK: a systematic review

Abstract:
The UK National Institute for Health and Care Excellence (NICE) guidance for the treatment of depression is widely followed and has international influence. According to these guidelines, antidepressant medications are recommended for moderate to severe depression. Nonetheless, antidepressants are increasingly prescribed, including for cases of subthreshold and mild depression. This may indicate that a proportion of depressed patients uses pharmacological interventions with unclear evidence-base, though other factors such as physical and mental health comorbidities need to be accounted for. This study aims to investigate the prevalence and trends of antidepressant prescriptions among community-dwelling adults diagnosed with depression according to NICE recommendations. We conducted a systematic review of PsycInfo, PubMed/MEDLINE, and Scopus databases. Observational studies reporting on the prevalence of antidepressant treatments in UK adults diagnosed with depression were sought. Fifteen studies were included. The prevalence of antidepressants for depression treatment ranged from 30.8 to 95% and mainly concerned selective serotonin reuptake inhibitors (SSRIs) among classes of antidepressant drugs. Little information about depression severity as well as comorbid conditions was reported. High prevalence rates of antidepressant drug use highlight the widespread adoption of pharmacological interventions, while also raising concerns about compliance with NICE guidelines. Careful assessment of depressive illness severity and comorbidities is needed to ensure the delivery of adequate care to people with depression. Systematic Review Registration Number (PROSPERO) CRD42023448152.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1007/s11126-024-10093-8

Authors


More by this author
Role:
Author
ORCID:
0000-0002-5191-8431
More by this author
Role:
Author
ORCID:
0000-0001-6411-9439
More by this author
Role:
Author
ORCID:
0009-0009-2865-9759
More by this author
Role:
Author
ORCID:
0000-0002-7544-826X
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Psychiatry
Oxford college:
Brasenose College
Role:
Author
ORCID:
0000-0001-5984-8696


More from this funder
Grant:
2022-C23.I01.P03.S0020-0000031


Publisher:
Springer
Journal:
Psychiatric Quarterly More from this journal
Volume:
95
Issue:
4
Pages:
731-746
Publication date:
2024-09-30
Acceptance date:
2024-09-23
DOI:
EISSN:
1573-6709
ISSN:
0033-2720
Pmid:
39347894


Language:
English
Keywords:
Subtype:
Review
Pubs id:
2035940
Local pid:
pubs:2035940
Deposit date:
2024-11-24

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP